Robert S. Langer, Sc.D, Founder
Dr. Langer, a co-founder of Acusphere, is an Institute Professor, the highest honor awarded to a faculty member, at the Massachusetts Institute of Technology (MIT) where he is also the Kenneth Germeshausen Professor of Chemical and Biomedical Engineering. He is an elected member of all three of the U.S. National Academies – the National Academy of Sciences, the Institute of Medicine and the National Academy of Engineering – and was the youngest person ever to receive this distinction. Dr. Langer has received over 170 major awards including the 2006 United States National Medal of Science; the Charles Stark Draper Prize, considered the equivalent of the Nobel Prize for engineers and the 2008 Millennium Prize, the world’s largest technology prize. He is the also the only engineer to receive the Gairdner Foundation International Award; 72 recipients of this award have subsequently received a Nobel Prize. Among numerous other awards Langer has received are the Dan David Prize in Materials Science (2005), the Albany Medical Center Prize in Medicine and Biomedical Research (2005), the largest prize in the U.S. for medical research, induction into the National Inventors Hall of Fame (2006), the Max Planck Research Award (2008) and the Prince of Asturias Award for Technical and Scientific Research (2008). Dr. Langer has served as a member of the U.S. FDA’s highest advisory board, SCIENCE, from 1995-2002 and as its Chairman from 1999-2002. Dr. Langer has served, at various times, on 15 boards of directors and 30 Scientific Advisory Boards of such companies as Wyeth, Mitsubishi Pharmaceuticals and Warner-Lambert.
William I. Ramage, D. Phil., Business Development Advisor
Dr. Ramage has served as a consultant to Acusphere since 1998. Previously Dr. Ramage was Vice President Business Development and Customer Services at DuPont-Merck (now Lantheus) and had major business responsibility for the leading nuclear perfusion agent, Cardiolite®, and in-licensed the ultrasound contrast agent, Definity®. Prior to joining Acusphere, Dr. Ramage was Vice President Business Development and Marketing at Molecular BioSystems, where he oversaw the approval and launch of Optison® in the U.S. and Europe. Dr. Ramage holds a B.Sc. from the University of Glasgow and a D.Phil. from Oxford University.